AIG:NYSEAmerican International Group, Inc. New Analysis
Data as of 2026-06-13 - not real-time
$75.74
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
American International Group (AIG) trades at $75.74, comfortably above its 20‑day SMA (75.48) but below the 50‑day (76.17) and 200‑day (77.81) averages, indicating a short‑term pull‑back within a longer‑term downtrend. The RSI of 51.6 is neutral, while the MACD histogram has turned positive (0.11) suggesting emerging bullish momentum. Volatility is elevated at ~26% over the past 30 days, yet the stock’s beta of 0.20 points to low systematic risk. Fundamentally, AIG’s P/E of 13.3 is well under the industry average of 16.8, the P/B is near parity at 0.99, and the dividend yield of 2.64% is supported by a 31.7% payout ratio and strong free cash flow. The DCF model values the shares at $253, implying a ~16% upside from current levels.
Material news includes the appointment of Thomas Stoddard as an independent director and the upcoming CEO transition to Eric Andersen on June 1 2026, underscoring a leadership refresh that could enhance risk management and capital allocation.
Material news includes the appointment of Thomas Stoddard as an independent director and the upcoming CEO transition to Eric Andersen on June 1 2026, underscoring a leadership refresh that could enhance risk management and capital allocation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support at $72.15
- Emerging bullish MACD signal
- Leadership transition adds short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervaluation with ~16% upside to DCF fair value
- Stable dividend yield and strong cash generation
- Improving technicals toward resistance at $78.92
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term value gap (DCF $253 vs $75.74)
- Low systematic risk (beta 0.20) and solid balance sheet
- Sustainable dividend and ongoing leadership renewal
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin11.84%
P/E Ratio13.3
ROE7.72%
ROA1.88%
Debt/Equity22.65
P/B Ratio1.0
Op. Cash Flow$3.5B
Free Cash Flow$9.5B
Industry P/E16.8
Technical Analysis
TrendBearish
RSI51.6
Support$72.15
Resistance$78.92
MA 20$75.48
MA 50$76.17
MA 200$77.81
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$253.29
Target Price$87.80
Upside/Downside15.92%
GradeUndervalued
TypeBlend
Dividend Yield2.64%
Risk Assessment
Beta0.20
Volatility25.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.